Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cerny

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 14, 1989
[Chemotherapy of bronchus carcinoma]R Joss, K Buser, T Cerny, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 22, 2008
Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapyE Von Rohr, F Gönner, G Schroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patientsT Cerny, A Küpfer, T Zeugin, et al.
Schweizerische Medizinische Wochenschrift|August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]B Roth, T Cerny, K W Brunner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Bioavailability of ifosfamide in patients with bronchial carcinomaT Cerny, J M Margison, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapyW Korte, C Jost, S Cogliatti, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1994
[Does non-conventional complementary therapies improve the quality of life of cancer patients? A critical literature review]C Hürny, P Heusser, J Bernhard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Oral bioavailability of mesna tabletsB Stofer-Vogel, T Cerny, M Borner, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancerM Früh, S Gillessen, T Cerny, et al.
International Journal of Cancer|February 15, 1987
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patientsT Cerny, V Blair, H Anderson, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 14, 1989
[Chemotherapy of bronchus carcinoma]R Joss, K Buser, T Cerny, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 22, 2008
Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapyE Von Rohr, F Gönner, G Schroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patientsT Cerny, A Küpfer, T Zeugin, et al.
Schweizerische Medizinische Wochenschrift|August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]B Roth, T Cerny, K W Brunner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Bioavailability of ifosfamide in patients with bronchial carcinomaT Cerny, J M Margison, N Thatcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapyW Korte, C Jost, S Cogliatti, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1994
[Does non-conventional complementary therapies improve the quality of life of cancer patients? A critical literature review]C Hürny, P Heusser, J Bernhard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Oral bioavailability of mesna tabletsB Stofer-Vogel, T Cerny, M Borner, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancerM Früh, S Gillessen, T Cerny, et al.
International Journal of Cancer|February 15, 1987
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patientsT Cerny, V Blair, H Anderson, et al.
Pageof 15